This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
News

HPV vaccine could prevent thousands of cancers over the next few decades

It is estimated that the human papilloma virus (HPV) vaccine programme in the UK could prevent over 100,000 HPV-related cancers in the next few decades.

HPV has been linked with 5 per cent of all cancers globally. More than 99 per cent of cervical cancers, 90 per cent of anal cancers, ~70 per cent of vaginal and vulvar cancers and >60 per cent of penile cancers are attributable to HPV.

The University of Warwick conducted a modelling study which estimates that the HPV vaccine programme could prevent up to 64,138 HPV-related cervical cancers and 49,649 other HPV-related cancers by 2058.

The HPV vaccine is being offered to girls free of cost by the NHS since 2008 and >80 per cent of women aged 15 to 24 years have been vaccinated till date. Starting in September 2019, the HPV vaccine programme will be offered to boys in school year 8 for the first time.

Seema Kennedy, Public Health Minister, said: "Programmes like this are at the heart of our work to help people live longer, healthier lives through the NHS Long Term Plan and I would encourage everyone who is eligible to take up this potentially life-saving vaccine."


References


YOU MAY ALSO LIKE